Innovotech Inc. reported that the Material Transfer and Collaboration Agreement with a global medical device company, announced on July 14, 2020, for Innovotech's InnovoSIL-1 silver periodate antimicrobial compound, has been terminated. InnovoSIL-1 antimicrobial silver's performance in terms of biocompatibility and antimicrobial activity was not a factor in the termination of the Agreement. InnovoSIL-1 antimicrobial silver continues to show outstanding antimicrobial performance, demonstrating anti-adherent and antibiofilm properties under a variety of challenging test conditions.

Innovotech is presently working with three industry collaborators who are pursuing a variety of applications for InnovoSIL-1 antimicrobial silver and expects to sign a Material Transfer Agreement with a fourth collaboration partner in the next few days.